CD8A and neoplasm: Tumor-derived extracellular vesicles can affect the function of B-cells in different ways, inducing antibodies production which, although capable of activating immune responses, do not have the antigenic potential of tumor-derived HLA-I binding peptides to activate the CD8+ T-cells.